triple-negative breast cancerTNBCLP-184chemoimmunotherapy
…ground Despite the widespread adoption of chemoimmunotherapy in triple-negative breast cancer (TNBC), the mechanisms by which cytotoxic chemotherapy engages …
35articles mentioning diseases
39disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: Triple-negative breast cancer ×
Triple-negative breast cancer
This disease is selected. Its supporting articles are shown below.
Articles mentioning Triple-negative breast cancer
35 articles · page 1 of 3triple-negative breast cancerhuman breast cancerPI-3065LAG-3PI3Kδ inhibitor
… to LAG-3. Indeed, while this approach in preclinical models of triple-negative breast cancer shows excellent tumor control, treatment is poorly tolerated an…
Colorectal cancerbreast cancercancerPhiladelphia-chromosome positive acute lymphoblastic leukaemiaHodgkin lymphomahypophysitismelanoma
… phase, and none are guideline-standard outside clinical trials.Colorectal cancer Globally, colorectal cancer affects approximately 1.9 million i…
TNBCtriple-negative breast cancerpembrolizumabdurvalumabnivolumabatezolizumabTriNetX
…search network to identify adult female patients diagnosed with TNBC (ER-/PR-/HER2-) who received at least one dose of an ICI (pembr…
Triple-negative breast cancer: a threshold-defined diagnostic category within a biological continuum
Triple-negative breast cancerTNBC
…Triple-negative breast cancer (TNBC) is defined in routine practice by the absence of oestrog…
triple-negative breast cancer4–1BBPD-L1
…Background The immunologically “cold” microenvironment of triple-negative breast cancer presents a major obstacle to treatment, conferring resistance t…
NSCLCtriple-negative breast cancerhead and neck cancernon-small cell lung cancerCYLDRUNX1
… identify novel potential mediators, including LoF of TGFBR2 in NSCLC, CYLD in head and neck cancer, and RUNX1 in triple-negative bre…
TNBCtriple-negative breast cancerhuman breast cancersacituzumab govitecan
…Cs), in promoting TNBC progression. A humanized TROP2 syngeneic TNBC model was used to assess the effects of TROP2-targeting in comb…
TNBCtriple-negative breast cancerpembrolizumabtertiary hospitalchemotherapy
…effective and economically sustainable approach for neoadjuvant TNBC treatment in European real-world settings.Conflict of Interest …
Triple-negative breast cancerTNBCpembrolizumabneoadjuvant chemotherapyCorticosteroidsKEYNOTE-522 trialneoadjuvant chemoimmunotherapy
…Triple-negative breast cancer (TNBC) is an aggressive subtype with high recurrence risk. The …
TNBCtriple-negative breast cancerCochrane LibraryWeb of ScienceMEDLINEEmbaseGoogle Scholar
…ity. No significant publication bias was detected.Conclusion In TNBC, AR expression appears to confer short-term DFS benefit but not…
LUAD4T1 breast cancertriple-negative breast cancerlung adenocarcinomaTNBCepalrestatLLC lung carcinoma mouse models
…sociated with poor prognosis and immune suppression in TNBC and LUAD. Notably, targeting AKR1B1 improves responses to ICIs in both b…